• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AV-TEMECULA-CT MITRACLIP XTR DELIVERY SYSTEM; MITRACLIP DELIVERY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AV-TEMECULA-CT MITRACLIP XTR DELIVERY SYSTEM; MITRACLIP DELIVERY SYSTEM Back to Search Results
Catalog Number CDS0602-XTR
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Angina (1710); Dyspnea (1816); Edema (1820); Low Blood Pressure/ Hypotension (1914); Renal Failure (2041); No Consequences Or Impact To Patient (2199); Heart Failure (2206); Cardiogenic Shock (2262); Test Result (2695)
Event Date 03/07/2019
Event Type  Death  
Manufacturer Narrative
(b)(4).During processing of this complaint, attempts were made to obtain complete event, patient and device information.The clip remains in the patient.Investigation is not yet complete.A follow up report will be submitted with all additional relevant information.
 
Event Description
This is filed for worsening heart failure, multi-organ failure, and death.It was reported that an initial mitraclip procedure was attempted on (b)(6) 2018 but was discontinued prior to any mitraclip being implanted.The septal puncture site was closed with an asd (atrial septal defect) closure device.On (b)(6) 2018, two mitraclips were implanted without a device issue, reducing the degenerative mitral regurgitation (mr) from grade 3+ to grade 1+.On (b)(6) 2019, the patient was hospitalized for worsening heart failure, increasing dyspnea with a mild cough, lower extremity edema, reoccurring intermittent thorax pain and acute on chronic renal insufficiency.Echocardiogram showed reduced left ventricular ejection fraction (20-25%) with global cardiac hyperkinesia, mitral valve sclerosis with discrete insufficiency and aortic valve sclerosis with insufficiency.The mitraclips remained stable and well seated on the leaflets.A left-right shunt was observed.Reportedly, the mitraclips had not caused or contributed to any tissue damage.The patient had become hypotensive with increased renal insufficiency and developed cardiogenic shock with multi-organ failure.On (b)(6) 2019, the patient expired.The cause of death was cardiovascular.The study physician indicated that it's unknown if the event is device related.No additional information was provided regarding this issue.
 
Manufacturer Narrative
(b)(4).Based on new information received from the physician that worsening heart failure, hospitalization, cardiogenic shock and multi-organ failure resulting in death was not related to the mitraclip device, this event would not be mdr reportable.Further investigation is not needed.
 
Event Description
Subsequent to the previous medwatch report, additional information was obtained: per physician, the worsening heart failure requiring hospitalization on (b)(4) 2019, with cardiogenic shock and multi-organ failure resulting in death, was unrelated to the mitraclip device and unrelated to the mitraclip procedure.There was no device malfunction.
 
Manufacturer Narrative
(b)(4).The device was not returned for evaluation and there was no reported device malfunction associated with mitraclip device.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Based on the information reviewed, death was a result of procedural circumstances (was cardiovascular and patient had gone into cardiogenic shock with multi-organ failure), and not related to mitraclip device.A definitive cause for the reported patient effects could not be determined.Although a conclusive cause for the reported patient effect(s), and the relationship to the device, if any, cannot be determined, there is no indication of a product quality issue with respect to manufacture, design or labeling.Hospitalization and test results are result of case specific circumstances.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MITRACLIP XTR DELIVERY SYSTEM
Type of Device
MITRACLIP DELIVERY SYSTEM
Manufacturer (Section D)
AV-TEMECULA-CT
abbott vascular
26531 ynez road
temecula CA 92591 4628
Manufacturer (Section G)
MENLO PARK, CA REG# 3005070406
abbott vascular
26531 ynez rd.
temecula CA 92591 4628
Manufacturer Contact
lindsey bell
abbott vascular
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key8670860
MDR Text Key147065061
Report Number2024168-2019-04427
Device Sequence Number1
Product Code NKM
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
P100009
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,s
Reporter Occupation Physician
Remedial Action Other
Type of Report Initial,Followup,Followup
Report Date 10/17/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date09/10/2019
Device Catalogue NumberCDS0602-XTR
Device Lot Number80910U169
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 05/20/2019
Initial Date FDA Received06/05/2019
Supplement Dates Manufacturer Received07/16/2019
09/27/2019
Supplement Dates FDA Received08/02/2019
10/17/2019
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured09/01/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
1 IMPLANTED MITRACLIP
Patient Outcome(s) Death;
Patient Age65 YR
Patient Weight129
-
-